Advanced machine learning (ML) technology was found beneficial in capturing the time sequence of clinical events for pancreatic cancer and predicting risk over several years, according to a presentation at the 2022 annual meeting of the American Association for Cancer Research, in New Orleans (poster LB55).
The researchers noted that currently, there are no reliable biomarkers or screening tools to detect pancreatic cancer early.
Inspiration to pursue artificial intelligence, according to the